Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Vet Parasitol. 2020 Dec 15;289:109336. doi: 10.1016/j.vetpar.2020.109336

Figure 3: BKI-1369 is effective at reducing nanoluciferase-tagged C. parvum from gamma-interferon knock out mice:

Figure 3:

BKI-1369 was administered orally at the doses shown (mpk = milligrams per kg), on day 6–10 post infection (P.I.) with 10,000 oocysts of Nluc-UGA1 C. parvum. The stool was isolated and relative luminescence units (RLU) are shown on the days P.I. Data from that published in (Hulverson et al., 2017a).